CP-154,526
Encyclopedia
CP-154,526 is a potent and selective antagonist
of the corticotropin releasing hormone receptor 1
developed by Pfizer
.
CP-154,526 is under investigation for the potential treatment of alcoholism
.
Receptor antagonist
A receptor antagonist is a type of receptor ligand or drug that does not provoke a biological response itself upon binding to a receptor, but blocks or dampens agonist-mediated responses...
of the corticotropin releasing hormone receptor 1
Corticotropin releasing hormone receptor 1
Corticotropin releasing hormone receptor 1 is a protein, also known as CRF1, with the latter now being the IUPHAR-recommended name...
developed by Pfizer
Pfizer
Pfizer, Inc. is an American multinational pharmaceutical corporation. The company is based in New York City, New York with its research headquarters in Groton, Connecticut, United States...
.
CP-154,526 is under investigation for the potential treatment of alcoholism
Alcoholism
Alcoholism is a broad term for problems with alcohol, and is generally used to mean compulsive and uncontrolled consumption of alcoholic beverages, usually to the detriment of the drinker's health, personal relationships, and social standing...
.